Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL ENDOMETRIAL ABLATION DEVICES SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8. COST ANALYSIS BREAKDOWN
9. TECHNONLOGY ROADMAP
10. INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11. REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12. REIMBURSEMENT FRAMEWORK
13. OPPUTUNITY MAP ANALYSIS
14. VALUE CHAIN ANALYSIS
15. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY PRODUCT TYPE
15.1 OVERVIEW
15.2 SYSTEM/EQUIPMENT
15.2.1 BY TYPE
15.2.1.1. RADIOFREQUENCY ABLATION DEVICES
15.2.1.1.1. MONOPOLAR RADIOFREQUENCY ABLATION DEVICES
15.2.1.1.2. BIOPOLAR RADIOFREQUENCY ABLATION DEVICES
15.2.1.2. CRYOABLATION DEVICES
15.2.1.2.1. PROBE CRYOABLATION DEVICES
15.2.1.2.2. BALLOON CRYOABLATION DEVICES
15.2.1.3. THERMAL BALLOON ABLATION DEVICES
15.2.1.3.1. HYDROTHERMAL BALLOON ABLATION DEVICES
15.2.1.3.2. GAS-FILLED THERMAL BALLOON ABLATION DEVICES
15.2.1.4. HYDROTHERMAL ABLATION DEVICES
15.2.1.5. MICROWAVE ABLATION DEVICES
15.2.1.6. LASER ABLATION DEVICES
15.2.1.7. OTHERS
15.2.2 BY MODALITY
15.2.2.1. STANDALONE
15.2.2.2. PORTABLE
15.2.2.3. BENCHTOP
15.3 CONSUMABLES
15.3.1 ELECTRODE
15.3.1.1. ABLATION SINGLE ELECTRODE KITS
15.3.1.2. ABLATION CLUSTER ELECTRODE KITS
15.3.1.3. ABLATION MULTIPLE ELECTRODE KITS
15.3.2 ABLATION SYSTEM GROUNDING PAD
15.3.3 ENDOMETRIAL ABLATION PROBES
15.3.3.1. STERILE
15.3.3.2. NON-STERILE
15.3.4 CANNULA
15.3.5 NEEDLES
15.3.6 CATHETERS
15.3.7 OTHERS
15.4 OTHERS
16. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY PORTABILITY
16.1 OVERVIEW
16.2 STANDALONE
16.3 PORTABLE
16.4 BENCHTOP
17. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY SITE
17.1 OVERVIEW
17.2 IN OFFICE PROCEDURE SITE
17.3 FACILITY BASED PROCEDURE SITE
18. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY
18.1 OVERVIEW
18.2 RADIOFREQUENCY ABLATION
18.3 CRYOABLATION
18.4 THERMAL BALLOON ABLATION
18.5 HYDROTHERMAL ABLATION
18.6 MICROWAVE ABLATION
18.7 LASER ABLATION
18.8 OTHERS
19. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNIQUE
19.1 OVERVIEW
19.2 ESECTOSCOPIC
19.2.1 SYSTEM/EQUIPMENT
19.2.2 CONSUMABLES
19.2.3 OTHERS
19.3 NON-RESECTOSCOPIC
19.3.1 SYSTEM/EQUIPMENT
19.3.2 CONSUMABLES
19.3.3 OTHERS
20. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY APPLICATION
20.1 OVERVIEW
20.2 ABNORMAL UTERINE BLEEDING (AUB)
20.2.1 SYSTEM/EQUIPMENT
20.2.2 CONSUMABLES
20.2.3 OTHERS
20.3 MENORRHAGIA (HEAVY MENSTRUAL BLEEDING)
20.3.1 SYSTEM/EQUIPMENT
20.3.2 CONSUMABLES
20.3.3 OTHERS
20.4 DYSMENORRHEA (PAINFUL MENSTRUATION)
20.4.1 SYSTEM/EQUIPMENT
20.4.2 CONSUMABLES
20.4.3 OTHERS
20.5 POLYPS
20.5.1 SYSTEM/EQUIPMENT
20.5.2 CONSUMABLES
20.5.3 OTHERS
20.6 FIBROIDS
20.6.1 SYSTEM/EQUIPMENT
20.6.2 CONSUMABLES
20.6.3 OTHERS
20.7 ADENOMYOSIS
20.7.1 SYSTEM/EQUIPMENT
20.7.2 CONSUMABLES
20.7.3 OTHERS
20.8 OTHERS
21. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY AGE GROUP
21.1 OVERVIEW
21.2 PRE-MENOPAUSAL
21.3 PERI-MENOPAUSAL
21.4 POST-MENOPAUSAL
22. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER
22.1 OVERVIEW
22.2 HOSPITALS
22.2.1 BY TYPE
22.2.1.1. PRIVATE
22.2.1.2. PUBLIC
22.3 CLINICAL LABORATORIES
22.4 DIAGNOSTIC IMAGING CENTERS
22.5 INDEPENDENT TREATMENT CENTRES
22.6 CATHERIZATION LABORATORIES
22.7 AMBULATORY SURGICAL CENTERS
22.8 OTHERS
23. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY DISTRIBUTION CHANNEL
23.1 OVERVIEW
23.2 DIRECT TENDER
23.3 RETAIL SALES
23.4 OTHERS
24. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, SWOT AND DBMR ANALYSIS
25. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, COMPANY LANDSCAPE
25.1 COMPANY SHARE ANALYSIS: GLOBAL
25.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
25.3 COMPANY SHARE ANALYSIS: EUROPE
25.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC
25.5 MERGERS & ACQUISITIONS
25.6 NEW PRODUCT DEVELOPMENT & APPROVALS
25.7 EXPANSIONS
25.8 REGULATORY CHANGES
25.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
26. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, BY REGION
GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
26.1 NORTH AMERICA
26.1.1 U.S.
26.1.2 CANADA
26.1.3 MEXICO
26.2 EUROPE
26.2.1 GERMANY
26.2.2 FRANCE
26.2.3 U.K.
26.2.4 ITALY
26.2.5 SPAIN
26.2.6 RUSSIA
26.2.7 TURKEY
26.2.8 BELGIUM
26.2.9 NETHERLANDS
26.2.10 SWITZERLAND
26.2.11 DENMARK
26.2.12 NORWAY
26.2.13 SWEDEN
26.2.14 FINLAND
26.2.15 POLAND
26.2.16 REST OF EUROPE
26.3 ASIA-PACIFIC
26.3.1 JAPAN
26.3.2 CHINA
26.3.3 SOUTH KOREA
26.3.4 INDIA
26.3.5 AUSTRALIA
26.3.6 SINGAPORE
26.3.7 THAILAND
26.3.8 MALAYSIA
26.3.9 INDONESIA
26.3.10 PHILIPPINES
26.3.11 VIETNAM
26.3.12 NEW ZEALAND
26.3.13 TAIWAN
26.3.14 REST OF ASIA-PACIFIC
26.4 SOUTH AMERICA
26.4.1 BRAZIL
26.4.2 ARGENTINA
26.4.3 REST OF SOUTH AMERICA
26.5 MIDDLE EAST AND AFRICA
26.5.1 SOUTH AFRICA
26.5.2 SAUDI ARABIA
26.5.3 UAE
26.5.4 EGYPT
26.5.5 ISRAEL
26.5.6 OMAN
26.5.7 QATAR
26.5.8 BAHRAIN
26.5.9 REST OF MIDDLE EAST AND AFRICA
26.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
27. GLOBAL ENDOMETRIAL ABLATION DEVICES MARKET, COMPANY PROFILE
27.1 HOLOGIC, INC.
27.1.1 COMPANY OVERVIEW
27.1.2 REVENUE ANALYSIS
27.1.3 GEOGRAPHIC PRESENCE
27.1.4 PRODUCT PORTFOLIO
27.1.5 RECENT DEVELOPMENTS
27.2 COOPERSURGICAL
27.2.1 COMPANY OVERVIEW
27.2.2 REVENUE ANALYSIS
27.2.3 GEOGRAPHIC PRESENCE
27.2.4 PRODUCT PORTFOLIO
27.2.5 RECENT DEVELOPMENTS
27.3 BOSTON SCIENTIFIC CORPORATION
27.3.1 COMPANY OVERVIEW
27.3.2 REVENUE ANALYSIS
27.3.3 GEOGRAPHIC PRESENCE
27.3.4 PRODUCT PORTFOLIO
27.3.5 RECENT DEVELOPMENTS
27.4 IDOMAN-MED
27.4.1 COMPANY OVERVIEW
27.4.2 REVENUE ANALYSIS
27.4.3 GEOGRAPHIC PRESENCE
27.4.4 PRODUCT PORTFOLIO
27.4.5 RECENT DEVELOPMENTS
27.5 OLYMPUS
27.5.1 COMPANY OVERVIEW
27.5.2 REVENUE ANALYSIS
27.5.3 GEOGRAPHIC PRESENCE
27.5.4 PRODUCT PORTFOLIO
27.5.5 RECENT DEVELOPMENTS
27.6 OMNITECH SYSTEMS, INC
27.6.1 COMPANY OVERVIEW
27.6.2 REVENUE ANALYSIS
27.6.3 GEOGRAPHIC PRESENCE
27.6.4 PRODUCT PORTFOLIO
27.6.5 RECENT DEVELOPMENTS
27.7 MEDTRONIC
27.7.1 COMPANY OVERVIEW
27.7.2 REVENUE ANALYSIS
27.7.3 GEOGRAPHIC PRESENCE
27.7.4 PRODUCT PORTFOLIO
27.7.5 RECENT DEVELOPMENTS
27.8 VELDANA MEDICAL
27.8.1 COMPANY OVERVIEW
27.8.2 REVENUE ANALYSIS
27.8.3 GEOGRAPHIC PRESENCE
27.8.4 PRODUCT PORTFOLIO
27.8.5 RECENT DEVELOPMENTS
27.9 CHANNEL MEDSYSTEMS, INC.
27.9.1 COMPANY OVERVIEW
27.9.2 REVENUE ANALYSIS
27.9.3 GEOGRAPHIC PRESENCE
27.9.4 PRODUCT PORTFOLIO
27.9.5 RECENT DEVELOPMENTS
27.10 GYNESONICS
27.10.1 COMPANY OVERVIEW
27.10.2 REVENUE ANALYSIS
27.10.3 GEOGRAPHIC PRESENCE
27.10.4 PRODUCT PORTFOLIO
27.10.5 RECENT DEVELOPMENTS
27.11 RF MEDICAL CO., LTD.
27.11.1 COMPANY OVERVIEW
27.11.2 REVENUE ANALYSIS
27.11.3 GEOGRAPHIC PRESENCE
27.11.4 PRODUCT PORTFOLIO
27.11.5 RECENT DEVELOPMENTS
27.12 LINA MEDICAL APS
27.12.1 COMPANY OVERVIEW
27.12.2 REVENUE ANALYSIS
27.12.3 GEOGRAPHIC PRESENCE
27.12.4 PRODUCT PORTFOLIO
27.12.5 RECENT DEVELOPMENTS
27.13 JOHNSON & JOHNSON SERVICES, INC
27.13.1 COMPANY OVERVIEW
27.13.2 REVENUE ANALYSIS
27.13.3 GEOGRAPHIC PRESENCE
27.13.4 PRODUCT PORTFOLIO
27.13.5 RECENT DEVELOPMENTS
27.14 OCON THERAPEUTICS
27.14.1 COMPANY OVERVIEW
27.14.2 REVENUE ANALYSIS
27.14.3 GEOGRAPHIC PRESENCE
27.14.4 PRODUCT PORTFOLIO
27.14.5 RECENT DEVELOPMENTS
27.15 JUNE MEDICAL
27.15.1 COMPANY OVERVIEW
27.15.2 REVENUE ANALYSIS
27.15.3 GEOGRAPHIC PRESENCE
27.15.4 PRODUCT PORTFOLIO
27.15.5 RECENT DEVELOPMENTS
27.16 KARL STORZ ENDOSCOPY-AMERICA, INC.
27.16.1 COMPANY OVERVIEW
27.16.2 REVENUE ANALYSIS
27.16.3 GEOGRAPHIC PRESENCE
27.16.4 PRODUCT PORTFOLIO
27.16.5 RECENT DEVELOPMENTS
27.17 MGB BERLIN
27.17.1 COMPANY OVERVIEW
27.17.2 REVENUE ANALYSIS
27.17.3 GEOGRAPHIC PRESENCE
27.17.4 PRODUCT PORTFOLIO
27.17.5 RECENT DEVELOPMENTS
27.18 GYNEX
27.18.1 COMPANY OVERVIEW
27.18.2 REVENUE ANALYSIS
27.18.3 GEOGRAPHIC PRESENCE
27.18.4 PRODUCT PORTFOLIO
27.18.5 RECENT DEVELOPMENTS
28. RELATED REPORTS
29. CONCLUSION
30. QUESTIONNAIRE
31. ABOUT DATA BRIDGE MARKET RESEARCH
